Analysts’ Perspective: Gilead Sciences (GILD), Canada Goose (GOOS), Nobilis Health (HLTH)

Brokerage Firm Oppenheimer upgraded Gilead Sciences, Inc. (NASDAQ:GILD) shares from Perform to Outperform rating with a price target of $85.

Gilead Sciences, Inc. discovers, develops, and commercializes therapeutics in the areas of unmet medical needs in the United States, Europe, and internationally.

*

Investment Analysts TD Securities upgrade Canada Goose Holdings Inc. (NYSE:GOOS) shares from Hold to Buy rating.

Canada Goose Holdings Inc. designs, manufactures, and sells premium outdoor apparel for men, women, youth, children, and babies.

*

Nobilis Health Corp (NYSEAMERICAN:HLTH) shares were upgraded by analysts at The Benchmark Company from Hold to Speculative Buy rating with a price target of $2.

Nobilis Health Corp. owns and manages ambulatory surgical centers (ASCs), and acute-care and surgical hospitals in the United States.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/